1. Home
  2. EVAX vs GRNQ Comparison

EVAX vs GRNQ Comparison

Compare EVAX & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • GRNQ
  • Stock Information
  • Founded
  • EVAX 2008
  • GRNQ 2013
  • Country
  • EVAX Denmark
  • GRNQ Malaysia
  • Employees
  • EVAX N/A
  • GRNQ N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • GRNQ EDP Services
  • Sector
  • EVAX Health Care
  • GRNQ Technology
  • Exchange
  • EVAX Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • EVAX 17.8M
  • GRNQ 10.6M
  • IPO Year
  • EVAX 2021
  • GRNQ 2018
  • Fundamental
  • Price
  • EVAX $2.93
  • GRNQ $1.41
  • Analyst Decision
  • EVAX Strong Buy
  • GRNQ
  • Analyst Count
  • EVAX 2
  • GRNQ 0
  • Target Price
  • EVAX $10.00
  • GRNQ N/A
  • AVG Volume (30 Days)
  • EVAX 68.5K
  • GRNQ 23.6K
  • Earning Date
  • EVAX 10-30-2025
  • GRNQ 11-12-2025
  • Dividend Yield
  • EVAX N/A
  • GRNQ N/A
  • EPS Growth
  • EVAX N/A
  • GRNQ N/A
  • EPS
  • EVAX N/A
  • GRNQ N/A
  • Revenue
  • EVAX $3,176,000.00
  • GRNQ $3,256,679.00
  • Revenue This Year
  • EVAX N/A
  • GRNQ N/A
  • Revenue Next Year
  • EVAX $425.50
  • GRNQ N/A
  • P/E Ratio
  • EVAX N/A
  • GRNQ N/A
  • Revenue Growth
  • EVAX 1042.45
  • GRNQ N/A
  • 52 Week Low
  • EVAX $1.20
  • GRNQ $0.80
  • 52 Week High
  • EVAX $16.69
  • GRNQ $2.50
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 51.89
  • GRNQ 48.04
  • Support Level
  • EVAX $2.81
  • GRNQ $1.21
  • Resistance Level
  • EVAX $3.04
  • GRNQ $1.51
  • Average True Range (ATR)
  • EVAX 0.21
  • GRNQ 0.10
  • MACD
  • EVAX -0.00
  • GRNQ 0.02
  • Stochastic Oscillator
  • EVAX 68.64
  • GRNQ 58.82

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

Share on Social Networks: